首頁 > 市場調查報告書 > 工業機械

人工智能精密農業

市場調查報告書

商品編碼

2044464

永續醫療設備市場預測至2034年－按產品類型、永續發展承諾、材料類型、應用、最終用戶和地區分類的全球分析

Sustainable Medical Devices Market Forecasts to 2034 - Global Analysis By Product Type, Sustainability Approach, Material Type, Application, End User, and By Geography

出版日期: 2026年05月11日 | 出版商:

Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，預計到 2026 年，全球永續醫療設備市場規模將達到 128 億美元，並在預測期內以 10.6% 的複合年成長率成長，到 2034 年將達到 287 億美元。

永續醫療設備是指在設計、製造和處置過程中均採用環保方法，最大限度地減少其在整個生命週期內對環境影響的醫療產品。這些器械採用可生物分解材料、回收零件和節能製造程序，同時維持患者照護所需的嚴格安全性和性能標準。該市場涵蓋從一次性器械和手術器械到植入式設備和診斷設備等各種產品，所有產品的設計目標都是減少醫療廢棄物、降低碳足跡，並在醫療保健領域推廣循環經濟原則。

醫療廢棄物問題日益嚴重，環境法規也面臨挑戰。

全球醫療廢棄物的產生量持續成長，已達到臨界水平，迫使醫療系統尋求永續的替代方案。手術室和患者照護設施每年產生數百萬噸廢棄物，其中大部分是不可生物分解的塑膠。主要市場嚴格的環境法規，包括歐盟的《一次性塑膠指令》以及世界各地類似的措施，正迫使醫療設備醫療設備品的強勁市場需求。

嚴格遵守有關醫療資料的規定

複雜的新醫療材料核准流程顯著延緩了永續替代品在臨床實務中的應用。生物聚合物和再生塑膠必須經過廣泛的生物相容性測試、滅菌驗證和臨床試驗，才能獲得FDA和EMA等監管機構的批准。雖然這些嚴格的要求對於保障病人安全至關重要，但它們也造成了巨大的時間和成本障礙，阻礙了製造商使用永續材料進行創新。醫療採購的保守性——可靠性和安全性往往優先於環境因素——進一步加劇了這些限制，從而限制了永續醫療設備取代傳統醫療器材的速度。

開發用於醫療用途的可生物分解生物聚合物

生物聚合物科學的進步為醫療設備的研發創造了前所未有的機遇，這些器械在完成其使命後能夠安全地分解。源自玉米、甘蔗和藻類等可再生資源的聚合物材料，如今能夠實現可控的分解過程，同時保持與傳統醫用塑膠相當的機械性能。這些創新使得相關應用範圍得以廣泛擴展，從隨骨骼癒合而溶解的臨時性整形外科固定裝置，到可吸收的手術縫合釘和無需在體內留下永久植入的藥物輸送系統，不一而足。抗菌生物聚合物和形狀記憶生物分解材料的研究不斷拓展其潛在應用範圍，這項技術有望成為永續醫療設備發展中的變革性力量。

缺乏醫用塑膠回收基礎設施

醫療廢棄物管理的特殊性極大地限制了循環經濟模式在醫用塑膠領域的實際應用。與一般消費品包裝不同，由於感染控制的要求，使用過的醫療設備必須遵循嚴格的處置程序，而且大多數一次性產品，無論其材料成分如何，最終都被焚燒處理，而沒有進行回收利用。即使是採用可回收材料設計的器械，也常常被納入受監管的醫療廢物處理流程，在這些流程中，回收利用要么被禁止，要么根本不切實際。缺乏標準化的醫用塑膠收集、淨化和再處理系統，削弱了製造商在永續發展方面的投入。即使是那些在設計時就考慮到可回收性的醫療設備，其材料也很少被回收利用，這威脅到永續醫療設備舉措的環境信譽和經濟可行性。

新冠疫情的影響：

新冠疫情為永續醫療設備帶來了複雜的挑戰，因為緊急應變的優先事項暫時將環境考量置於次要地位。個人防護工具、檢測用品和一次性醫療器材的需求激增，導致廢棄物數量空前成長，迫使製造商優先考慮生產速度和產量，而非材料的永續性。然而，疫情也提高了人們對醫療供應鏈脆弱性和廢棄物管理不善的認知，促使醫療系統重新審視其對一次性產品的依賴。疫情過後，許多醫療機構認知到，減少對一次性產品的依賴（這些產品在危機期間造成了巨大的廢棄物負擔）對於構建具有韌性的醫療系統至關重要，並加快了永續採購政策的實施，最終推動了永續醫療設備市場的進步。

在預測期內，生物聚合物細分市場預計將佔據最大的市場佔有率。

預計在預測期內，生物聚合物領域將佔據最大的市場佔有率，這主要得益於其良好的生物相容性、可再生性和在各種醫療應用中的多功能性。植物來源的材料，例如聚乳酸、聚羥基烷酯和澱粉基聚合物，具有可預測的分解特性，同時避免了傳統醫用塑膠對石油基材料的依賴。它們的應用範圍涵蓋縫合線、藥物傳輸系統、組織工程支架和臨時植入等領域，其安全性已在臨床環境中得到驗證。領先的醫療設備製造商正在擴展其生物聚合物產品線，以滿足對醫療永續性的需求，同時，更低的生產成本也使這些材料在與傳統材料的競爭中日益增強，從而鞏固了其市場主導地位。

在預測期內，整形外科領域預計將呈現最高的複合年成長率。

在預測期內，整形外科領域預計將呈現最高的成長率，這反映了骨骼修復和關節重建永續創新的巨大潛力。由可生物分解聚合物和鎂合金製成的臨時性整形外科植入，例如螺絲、鋼板和鋼針，無需二次取出手術，同時減少了永久性植入造成的廢棄物。回收材料和生物基材料擴大應用於矯正器具、石膏和外固定裝置。全球人口老化推動了對整形外科手術的需求，加上人們對可生物吸收固定裝置的偏好日益成長，為市場擴張創造了巨大的機會。永續骨移植替代品和軟骨修復材料的技術進步，進一步加速了它們在整形外科實踐中的應用。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其先進的醫療保健基礎設施、高度的環保意識和積極的法規結構。該地區領先的醫療設備製造商認知到環境責任和競爭優勢的重要性，並正在投入大量資源用於永續產品開發。美國和加拿大的醫療保健系統正面臨著來自保險公司、投資者和患者群體的日益成長的壓力，要求其展現對環境的責任感。政府在公共醫療保健領域推行的促進永續採購的舉措，進一步加速了永續採購的普及。醫療設備研究機構的集中以及完善的分銷網路，確保了北美在整個預測期內將保持其主導地位。

複合年成長率最高的地區：

在預測期內，受歐盟積極的永續性政策和循環經濟行動計畫的推動，歐洲地區預計將呈現最高的複合年成長率。該地區全面的法規結構，包括「歐洲綠色交易」和醫療設備回收指令，設定了具有約束力的目標，要求醫療保健系統和製造商優先考慮永續的替代方案。消費者日益增強的環保意識正轉化為病患對環保醫療保健方案的需求。在政府研究資金和產業聯合舉措的支持下，歐洲領先的醫療設備醫療設備正在生物聚合物基和可再加工醫療設備領域引領創新。隨著各成員國對永續發展要求的日益嚴格，歐洲正迅速發展成為永續的醫療設備市場。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

企業概況
- 對其他市場參與者（最多 3 家公司）進行全面分析
- 對主要公司進行SWOT分析（最多3家公司）
區域細分
- 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
競爭性標竿分析
- 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
世界其他地區（RoW）
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲國家

第11章策略市場資訊

工業價值網路和供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第12章產業趨勢與策略舉措

併購
夥伴關係、聯盟和合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第13章：公司簡介

Medtronic plc
Johnson & Johnson
Stryker Corporation
Siemens Healthineers AG
GE HealthCare Technologies Inc.
Philips NV
Becton Dickinson and Company
Boston Scientific Corporation
Abbott Laboratories
Fresenius Medical Care AG
Terumo Corporation
Nipro Corporation
Hologic Inc.
Zimmer Biomet Holdings Inc.
Smith & Nephew plc
Edwards Lifesciences Corporation

簡介目錄圖表

Product Code: SMRC36253

According to Stratistics MRC, the Global Sustainable Medical Devices Market is accounted for $12.8 billion in 2026 and is expected to reach $28.7 billion by 2034 growing at a CAGR of 10.6% during the forecast period. Sustainable medical devices are healthcare products designed, manufactured, and disposed of using environmentally responsible practices that minimize ecological impact throughout their lifecycle. These devices incorporate biodegradable materials, recycled components, and energy-efficient production methods while maintaining strict safety and performance standards required for patient care. The market encompasses everything from single-use instruments and surgical tools to implantable devices and diagnostic equipment, all engineered to reduce medical waste, lower carbon footprints, and promote circular economy principles within the healthcare sector.

Market Dynamics:

Driver:

Growing healthcare waste crisis and environmental regulations

The escalating volume of medical waste generated globally has reached critical levels, pushing healthcare systems toward sustainable alternatives. Operating rooms and patient care facilities produce millions of tons of waste annually, much of which is plastic-based and non-biodegradable. Stringent environmental regulations in major markets, including the European Union's Single-Use Plastics Directive and similar measures worldwide, are compelling medical device manufacturers to redesign products for reduced environmental impact. Healthcare institutions facing pressure from regulators and environmentally conscious patients are actively seeking suppliers who can demonstrate meaningful sustainability commitments, creating strong market demand for eco-friendly medical device alternatives.

Restraint:

Stringent regulatory compliance for medical materials

The complex approval pathways for new medical materials significantly slow the introduction of sustainable alternatives into clinical practice. Biopolymers and recycled plastics must undergo extensive biocompatibility testing, sterilization validation, and clinical trials before receiving regulatory clearance from authorities such as the FDA and EMA. These rigorous requirements, while necessary for patient safety, create substantial time and cost barriers that discourage manufacturers from pursuing sustainable material innovations. The conservative nature of healthcare procurement, where reliability and proven safety often outweigh environmental considerations, further compounds this restraint, limiting the speed at which sustainable devices can replace conventional options.

Opportunity:

Development of biodegradable biopolymers for medical applications

Advances in biopolymer science are creating unprecedented opportunities for medical devices that safely decompose after their intended use. Polymeric materials derived from renewable sources such as corn, sugarcane, and algae can now achieve mechanical properties comparable to traditional medical plastics while offering controlled degradation profiles. These innovations enable applications ranging from temporary orthopedic fixation devices that dissolve as bone heals, to dissolvable surgical staples and drug delivery systems that leave no permanent implant behind. Research into antimicrobial biopolymers and shape-memory biodegradable materials continues to expand potential applications, positioning this technology as a transformative force in sustainable medical device development.

Threat:

Limited recycling infrastructure for medical plastics

The specialized nature of medical waste management severely constrains the practical implementation of circular economy models for healthcare plastics. Unlike consumer packaging, used medical devices face strict disposal protocols due to infection control requirements, with most single-use items incinerated rather than recycled regardless of material composition. Even devices designed from recyclable materials often enter regulated medical waste streams where recycling is prohibited or impractical. The absence of standardized collection, decontamination, and reprocessing systems for medical plastics undermines manufacturer sustainability investments, as devices designed for recyclability rarely achieve actual material recovery, threatening the environmental credibility and economic viability of sustainable device initiatives.

Covid-19 Impact:

The COVID-19 pandemic presented complex challenges for sustainable medical devices as emergency response priorities temporarily overshadowed environmental considerations. The surge in demand for personal protective equipment, testing supplies, and disposable medical instruments led to unprecedented waste volumes, with manufacturers prioritizing production speed and volume over material sustainability. However, the pandemic also heightened awareness of medical supply chain vulnerabilities and waste management failures, prompting healthcare systems to reconsider single-use dependency. Post-pandemic, many institutions have accelerated sustainable procurement policies, recognizing that resilient healthcare requires reducing reliance on disposable products that created massive waste burdens during the crisis, ultimately advancing the sustainable devices market.

The Biopolymers segment is expected to be the largest during the forecast period

The Biopolymers segment is expected to account for the largest market share during the forecast period, driven by their biocompatibility, renewability, and versatility across multiple medical applications. These plant-based materials, including polylactic acid, polyhydroxyalkanoates, and starch-based polymers, offer predictable degradation profiles while avoiding the petroleum dependence of conventional medical plastics. Their use spans sutures, drug delivery systems, tissue engineering scaffolds, and temporary implants, with established safety records in clinical practice. Major medical device manufacturers are expanding biopolymer portfolios to address healthcare sustainability demands, while falling production costs make these materials increasingly competitive with traditional options, cementing their dominant market position.

The Orthopedics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Orthopedics segment is predicted to witness the highest growth rate, reflecting the significant potential for sustainable innovation in bone repair and joint replacement procedures. Temporary orthopedic implants such as screws, plates, and pins made from biodegradable polymers and magnesium alloys eliminate the need for secondary removal surgeries while reducing permanent implant waste. Recycled and bio-based materials are increasingly used in braces, casts, and external fixation devices. The aging global population driving demand for orthopedic procedures, combined with growing preference for bioresorbable fixation devices, creates substantial market expansion opportunities. Technological advances in sustainable bone graft substitutes and cartilage repair materials further accelerate adoption across orthopedic practices.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by advanced healthcare infrastructure, strong environmental awareness, and proactive regulatory frameworks. The region's dominant medical device manufacturers have committed substantial resources to sustainable product development, recognizing both environmental responsibility and competitive advantage. Healthcare systems across the United States and Canada face increasing pressure from insurance providers, investors, and patient populations to demonstrate environmental stewardship. Government initiatives promoting sustainable procurement in publicly funded healthcare further accelerate adoption. The concentration of medical device research institutions and established distribution networks ensures North America maintains its leadership position throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR, driven by the European Union's aggressive sustainability policies and circular economy action plans. The region's comprehensive regulatory framework, including the European Green Deal and medical device recycling directives, creates binding targets that compel healthcare systems and manufacturers to prioritize sustainable alternatives. Strong consumer environmental consciousness translates into patient demand for eco-responsible healthcare options. Leading European medical device companies are pioneering innovations in biopolymer-based and reprocessed devices, supported by government research funding and collaborative industry initiatives. As sustainability requirements tighten across member states, Europe rapidly emerges as the fastest-growing market for sustainable medical devices.

Key players in the market

Some of the key players in Sustainable Medical Devices Market include Medtronic plc, Johnson & Johnson, Stryker Corporation, Siemens Healthineers AG, GE HealthCare Technologies Inc., Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, Abbott Laboratories, Fresenius Medical Care AG, Terumo Corporation, Nipro Corporation, Hologic Inc., Zimmer Biomet Holdings Inc., Smith & Nephew plc, and Edwards Lifesciences Corporation.

Key Developments:

In April 2026, Siemens Healthineers received FDA clearance for its latest "helium-free" MRI system, which utilizes a sealed cooling circuit to virtually eliminate the need for liquid helium, addressing global supply shortages and environmental concerns associated with helium extraction.

In February 2026, GE HealthCare introduced the SIGNA(TM) Bolt, a 3.0T MRI system designed with a "sustainable-first" architecture that reduces power consumption during idle states while maintaining ultra-high-definition imaging capabilities.

In January 2026, Philips N.V. announced a strategic expansion of its "Circular Edition" portfolio, which offers refurbished and upgraded medical imaging equipment (MRI and CT) to hospitals, reducing waste and the carbon footprint of new hardware manufacturing.

Product Types Covered:

Diagnostic Devices
Therapeutic Devices
Monitoring Devices
Surgical Instruments
Implantable Devices
Drug Delivery Devices
Other Product Types

Sustainability Approaches Covered:

Reusable Devices
Recyclable Devices
Energy-Efficient Devices
Low-Carbon Devices

Material Types Covered:

Biopolymers
Recycled Plastics
Metals
Glass & Ceramics
Other Material Types

Applications Covered:

Cardiology
Orthopedics
Neurology
Oncology
General Surgery
Diagnostic Imaging
Diabetes Care
Other Applications

End Users Covered:

Hospitals & Ambulatory Surgical Centers
Clinics
Home Healthcare
Diagnostic Laboratories
Research & Academic Institutes

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Sustainable Medical Devices Market, By Product Type

5.1 Diagnostic Devices
5.2 Therapeutic Devices
5.3 Monitoring Devices
5.4 Surgical Instruments
5.5 Implantable Devices
5.6 Drug Delivery Devices
5.7 Other Product Types

6 Global Sustainable Medical Devices Market, By Sustainability Approach

6.1 Reusable Devices
6.2 Recyclable Devices
6.3 Energy-Efficient Devices
6.4 Low-Carbon Devices

7 Global Sustainable Medical Devices Market, By Material Type

7.1 Biopolymers
7.2 Recycled Plastics
7.3 Metals
7.4 Glass & Ceramics
7.5 Other Material Types

8 Global Sustainable Medical Devices Market, By Application

8.1 Cardiology
8.2 Orthopedics
8.3 Neurology
8.4 Oncology
8.5 General Surgery
8.6 Diagnostic Imaging
8.7 Diabetes Care
8.8 Other Applications

9 Global Sustainable Medical Devices Market, By End User

9.1 Hospitals & Ambulatory Surgical Centers
9.2 Clinics
9.3 Home Healthcare
9.4 Diagnostic Laboratories
9.5 Research & Academic Institutes

10 Global Sustainable Medical Devices Market, By Geography

10.1 North America
- 10.1.1 United States
- 10.1.2 Canada
- 10.1.3 Mexico
10.2 Europe
- 10.2.1 United Kingdom
- 10.2.2 Germany
- 10.2.3 France
- 10.2.4 Italy
- 10.2.5 Spain
- 10.2.6 Netherlands
- 10.2.7 Belgium
- 10.2.8 Sweden
- 10.2.9 Switzerland
- 10.2.10 Poland
- 10.2.11 Rest of Europe
10.3 Asia Pacific
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Australia
- 10.3.6 Indonesia
- 10.3.7 Thailand
- 10.3.8 Malaysia
- 10.3.9 Singapore
- 10.3.10 Vietnam
- 10.3.11 Rest of Asia Pacific
10.4 South America
- 10.4.1 Brazil
- 10.4.2 Argentina
- 10.4.3 Colombia
- 10.4.4 Chile
- 10.4.5 Peru
- 10.4.6 Rest of South America
10.5 Rest of the World (RoW)
- 10.5.1 Middle East
  - 10.5.1.1 Saudi Arabia
  - 10.5.1.2 United Arab Emirates
  - 10.5.1.3 Qatar
  - 10.5.1.4 Israel
  - 10.5.1.5 Rest of Middle East
- 10.5.2 Africa
  - 10.5.2.1 South Africa
  - 10.5.2.2 Egypt
  - 10.5.2.3 Morocco
  - 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

11.1 Industry Value Network and Supply Chain Assessment
11.2 White-Space and Opportunity Mapping
11.3 Product Evolution and Market Life Cycle Analysis
11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

12.1 Mergers and Acquisitions
12.2 Partnerships, Alliances, and Joint Ventures
12.3 New Product Launches and Certifications
12.4 Capacity Expansion and Investments
12.5 Other Strategic Initiatives

13 Company Profiles

13.1 Medtronic plc
13.2 Johnson & Johnson
13.3 Stryker Corporation
13.4 Siemens Healthineers AG
13.5 GE HealthCare Technologies Inc.
13.6 Philips N.V.
13.7 Becton Dickinson and Company
13.8 Boston Scientific Corporation
13.9 Abbott Laboratories
13.10 Fresenius Medical Care AG
13.11 Terumo Corporation
13.12 Nipro Corporation
13.13 Hologic Inc.
13.14 Zimmer Biomet Holdings Inc.
13.15 Smith & Nephew plc
13.16 Edwards Lifesciences Corporation

簡介目錄圖表

List of Tables

Table 1 Global Sustainable Medical Devices Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Sustainable Medical Devices Market Outlook, By Product Type (2023-2034) ($MN)
Table 3 Global Sustainable Medical Devices Market Outlook, By Diagnostic Devices (2023-2034) ($MN)
Table 4 Global Sustainable Medical Devices Market Outlook, By Therapeutic Devices (2023-2034) ($MN)
Table 5 Global Sustainable Medical Devices Market Outlook, By Monitoring Devices (2023-2034) ($MN)
Table 6 Global Sustainable Medical Devices Market Outlook, By Surgical Instruments (2023-2034) ($MN)
Table 7 Global Sustainable Medical Devices Market Outlook, By Implantable Devices (2023-2034) ($MN)
Table 8 Global Sustainable Medical Devices Market Outlook, By Drug Delivery Devices (2023-2034) ($MN)
Table 9 Global Sustainable Medical Devices Market Outlook, By Other Product Types (2023-2034) ($MN)
Table 10 Global Sustainable Medical Devices Market Outlook, By Sustainability Approach (2023-2034) ($MN)
Table 11 Global Sustainable Medical Devices Market Outlook, By Reusable Devices (2023-2034) ($MN)
Table 12 Global Sustainable Medical Devices Market Outlook, By Recyclable Devices (2023-2034) ($MN)
Table 13 Global Sustainable Medical Devices Market Outlook, By Energy-Efficient Devices (2023-2034) ($MN)
Table 14 Global Sustainable Medical Devices Market Outlook, By Low-Carbon Devices (2023-2034) ($MN)
Table 15 Global Sustainable Medical Devices Market Outlook, By Material Type (2023-2034) ($MN)
Table 16 Global Sustainable Medical Devices Market Outlook, By Biopolymers (2023-2034) ($MN)
Table 17 Global Sustainable Medical Devices Market Outlook, By Recycled Plastics (2023-2034) ($MN)
Table 18 Global Sustainable Medical Devices Market Outlook, By Metals (2023-2034) ($MN)
Table 19 Global Sustainable Medical Devices Market Outlook, By Glass & Ceramics (2023-2034) ($MN)
Table 20 Global Sustainable Medical Devices Market Outlook, By Other Material Types (2023-2034) ($MN)
Table 21 Global Sustainable Medical Devices Market Outlook, By Application (2023-2034) ($MN)
Table 22 Global Sustainable Medical Devices Market Outlook, By Cardiology (2023-2034) ($MN)
Table 23 Global Sustainable Medical Devices Market Outlook, By Orthopedics (2023-2034) ($MN)
Table 24 Global Sustainable Medical Devices Market Outlook, By Neurology (2023-2034) ($MN)
Table 25 Global Sustainable Medical Devices Market Outlook, By Oncology (2023-2034) ($MN)
Table 26 Global Sustainable Medical Devices Market Outlook, By General Surgery (2023-2034) ($MN)
Table 27 Global Sustainable Medical Devices Market Outlook, By Diagnostic Imaging (2023-2034) ($MN)
Table 28 Global Sustainable Medical Devices Market Outlook, By Diabetes Care (2023-2034) ($MN)
Table 29 Global Sustainable Medical Devices Market Outlook, By Other Applications (2023-2034) ($MN)
Table 30 Global Sustainable Medical Devices Market Outlook, By End User (2023-2034) ($MN)
Table 31 Global Sustainable Medical Devices Market Outlook, By Hospitals & Ambulatory Surgical Centers (2023-2034) ($MN)
Table 32 Global Sustainable Medical Devices Market Outlook, By Clinics (2023-2034) ($MN)
Table 33 Global Sustainable Medical Devices Market Outlook, By Home Healthcare (2023-2034) ($MN)
Table 34 Global Sustainable Medical Devices Market Outlook, By Diagnostic Laboratories (2023-2034) ($MN)
Table 35 Global Sustainable Medical Devices Market Outlook, By Research & Academic Institutes (2023-2034) ($MN)